Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: Global

Allianz Biotechnologie

+ Add to Watchlist

DJFF:TH

182.1840 EUR 1.1640 0.64%

As of 02:00:08 ET on 05/22/2015.

Snapshot for Allianz Biotechnologie (DJFF)

Open: 182.1840 High - Low: 182.1840 - 182.1840 Primary Exchange: Tradegate
Volume: 28 52-Week Range: 102.5700 - 193.8340 Beta vs NBI: 0.9216

ETF Chart for DJFF

No chart data available.
  • DJFF:TH 182.1840
  • 1D
  • 1M
  • 1Y
181.0200
Interactive DJFF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DJFF

Allianz Biotechnologie is an open-end investment fund incorporated in Germany. The Fund's objective is growth. The Fund invests primarily in stocks, warrants and profit sharing certificates. The Fund may also invest in bonds withwarrants and convertible debentures issued by pharmaceutical and biotechnology corporations worldwide.

Inception Date: 1998-01-09 Telephone: 49-69-24431-140 Tel
Managers: -
Web Site: www.allianzglobalinvestors.de

Fundamentals for DJFF

NAV -
Assets (M) (on 2015-05-22) 380.1464
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for DJFF

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for DJFF

1-Month -3.03% 1-Year +81.73%
3-Month - 3-Year +37.72%
Year To Date - 5-Year -
Expense Ratio 2.05

Top Fund Holdings for DJFF

Filing Date: 01/31/2015
Name Position Value % of Total
Biogen Inc 88,920 27,684,394 7.700%
Celgene Corp 252,310 26,878,584 7.476%
Alexion Pharmaceuticals Inc 157,710 26,138,819 7.270%
Vertex Pharmaceuticals Inc 223,500 22,483,752 6.254%
Regeneron Pharmaceuticals Inc 45,000 16,445,122 4.574%
Medivation Inc 157,070 14,942,699 4.156%
Incyte Corp 201,500 14,445,501 4.018%
Amgen Inc 102,510 14,127,752 3.929%
Illumina Inc 78,430 13,825,015 3.845%
Mallinckrodt PLC 134,150 12,856,815 3.576%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil